|
||
Date of Report (Date of earliest event reported)
|
||
|
||
(Exact name of registrant as specified in its charter)
|
|
|
|
||
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
|
||
(Address of principal executive offices and zip code)
|
||
(
|
||
(Registrant’s telephone number, including area code)
|
||
N/A
|
||
(Former name or former address, if changed since last report)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Item 7.01 |
Regulation FD Disclosure.
|
Item 9.01 |
Financial Statements and Exhibits.
|
(d)
|
Exhibits.
|
Letter to Shareholders, excerpted from the Nu Skin Enterprises, Inc. 2020 Annual Report to Shareholders.
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
NU SKIN ENTERPRISES, INC.
|
||
(Registrant)
|
||
/s/ Mark H. Lawrence
|
||
Mark H. Lawrence
|
||
Chief Financial Officer
|
||
Date: April 19, 2021
|
• |
Customer growth of 34%, led by Americas/Pacific with 84% growth
|
• |
Achieving greater balance in our geographic profile
|
• |
Improving trends and stabilization in Mainland China aided by the ageLOC Boost™ product preview and focus on a digital-first business model
|
• |
Decreasing our average customer age, which is a key to accelerating product adoption and sales growth
|
• |
Rolling out ageLOC Boost™ and Nutricentials Bioadaptive Skin Care™, which generated approximately $100 million in second half sales
|
• |
Delivering manufacturing growth and stability to meet increased demand and minimize disruptions from COVID-19 through efficient management of our global supply chain
|
Document and Entity Information |
Apr. 19, 2021 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Apr. 19, 2021 |
Entity Registrant Name | NU SKIN ENTERPRISES, INC. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-12421 |
Entity Tax Identification Number | 87-0565309 |
Entity Address, Address Line One | 75 West Center Street |
Entity Address, City or Town | Provo |
Entity Address, State or Province | UT |
Entity Address, Postal Zip Code | 84601 |
City Area Code | 801 |
Local Phone Number | 345-1000 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001021561 |
Title of 12(b) Security | Class A Common Stock, $.001 par value |
Trading Symbol | NUS |
Security Exchange Name | NYSE |
I81'Y0R07YVF-8K_==;&Y
M0
[9W8N;?E"OZ9!LFB7GR!4F^=R9[+ =6% M(4VN#ZMWV^^2? @3WXO^PA[]P%H2A<\*E?(^B:9R\$:)XNGZG1+8ONJM$BAK M]UY)'D4\C+)X/]XL,:TAJ3WA\-LE2H+Z?@GHUPWE^:LNU9P#.I!T2>>,]9+K M86C7.ZC'NYJG$5^\4-4[YJ'U!*DW3+V-^U(*3+[FV3;[C\S7@'LYI!">AQQ MS8U<S1- MHM /TS!>?O)2=O;VU&]%S +Q6!H0-'DHK=DY>R1M KM8: \[JH7%(=N$#2 V MV[J"N;('$]05B3,6'_HE _20&U@84CV9T*/L MG5)^>JTZM,OEY0K3);O8^DC)2_K$RN;9B^&O*ZU*B5:#LC&XH*];AFU=V'$V M9PJRA0+E$E1H^D"Y?6W)7HL L0\FR65@\2U^XF1IGJ[9)_YSBHNF,/^YOK/_ M 5!+ P04 " G,)-2[Z
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end